SAFETY EVALUATION STUDIES ON OXISURAN, A DIFFERENTIAL INHIBITOR OF CELL-MEDIATED HYPERSENSITIVITY

被引：13

作者：

BRIZIARELLI, G ^{[1
]}

ABRUTYN, D ^{[1
]}

TORNABEN, JA ^{[1
]}

SCHWARTZ, E ^{[1
]}

机构：

[1] WARNER LAMBERT RES INST,MORRIS PLAINS,NJ 07950

来源：

TOXICOLOGY AND APPLIED PHARMACOLOGY | 1976年 / 36卷 / 01期

关键词：

D O I：

10.1016/0041-008X(76)90026-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：49 / 64

页数：16

相关论文

共 26 条

[1] ABELL LL, 1952, J BIOL CHEM, V195, P357
[2] BENOTTI J, 1963, CLIN CHEM, V9, P408
[3] CASEY T. P., 1968, CLIN EXP IMMUNOL, V3, P305
[4] AZATHIOPRINE THERAPY OF AUTOIMMUNE DISEASES
CORLEY, CC
LESSNER, HE
LARSEN, WE
[J]. AMERICAN JOURNAL OF MEDICINE, 1966, 41 (03) : 404 - +
[5] DISPOSITION AND BIOTRANSFORMATION OF C-14 OXISURAN IN DOG
CREW, MC
MELGAR, MD
HAYNES, LJ
GALA, RL
DICARLO, FJ
[J]. XENOBIOTICA, 1972, 2 (05) : 431 - &
[6] ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS .3. ADVERSE EFFECTS AND THERAPEUTIC PROBLEMS
CRIDLAND, MD
[J]. DRUGS, 1972, 3 (05) : 352 - &
[7] METABOLISM OF OXISURAN, AN IMMUNOSUPPRESSANT, BY RAT
DICARLO, FJ
GALA, RL
HAYNES, LJ
CREW, MC
[J]. XENOBIOTICA, 1972, 2 (02) : 159 - &
[8] FORBES IJ, 1973, MED J AUSTRALIA, V1, P749
[9] INFLUENCE OF OXISURAN, A DIFFERENTIAL INHIBITOR OF CELL-MEDIATED HYPERSENSITIVITY, ON ALLOGRAFT SURVIVAL AND HUMORAL IMMUNITY
FOX, AE
GAWLAK, DL
BALLANTYNE, DL
FREEDMAN, HH
[J]. TRANSPLANTATION, 1973, 15 (04) : 389 - 394
[10] INHIBITION BY OXISURAN OF CELL-MEDIATED HYPERSENSITIVITY BY DECREASE IN NUMBERS OF SPECIFICALLY SENSITIZED CELLS
FOX, AE
GINGOLD, JL
FREEDMAN, HH
[J]. INFECTION AND IMMUNITY, 1973, 8 (04) : 549 - 554